Simplex Trading
ADMS

Simplex Trading’s Adamas Pharmaceuticals ADMS Stock Holding History

Simplex Trading’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,600
Closed -$8K – 11952
2021
Q3 		$8K Buy
1,600
+600
+60% +$2.91K ﹤0.01% 9090
2021
Q2 		$5K Buy
1,000
+973
+3,604% +$5.04K ﹤0.01% 9506
2021
Q1 		$12K Buy
+27
New +$141 ﹤0.01% 7828
2020
Q2 		– Sell
-59
Closed -$17K – 8694
2020
Q1 		$17K Buy
59
+19
+48% +$85 ﹤0.01% 6108
2019
Q4 		$15K Sell
40
-14
-26% -$67 ﹤0.01% 6172
2019
Q3 		$27K Buy
54
+49
+980% +$303 ﹤0.01% 5589
2019
Q2 		$3K Sell
5
-34
-87% -$196 ﹤0.01% 6694
2019
Q1 		$27K Buy
+39
New +$351 ﹤0.01% 5513
2018
Q4 		– Sell
-245
Closed -$490K – 8155
2018
Q3 		$490K Buy
+245
New +$5.75K ﹤0.01% 2650
2018
Q2 		– Sell
-13
Closed -$5K – 8110
2018
Q1 		$5K Buy
+13
New +$410 ﹤0.01% 4705
2017
Q4 		– Sell
-162
Closed -$9K – 6985
2017
Q3 		$9K Buy
+162
New +$2.97K ﹤0.01% 3918

Simplex Trading's ADMS Position: Q2 2021 in Review

Simplex Trading sold out of Adamas Pharmaceuticals (ADMS) in Q2 2021, closing a stake of 3,236 shares — an estimated $16.7K sold.

Simplex Trading first reported a position in ADMS in Q4 2015 and held it in 14 quarters. The position peaked at $762K in Q3 2017. 67 funds tracked by Wall St. Rank hold ADMS as of Q2 2021.

  • Simplex Trading reported no remaining Adamas Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Simplex Trading sold 3,236 Adamas Pharmaceuticals shares in Q2 2021, an estimated $16.7K.
  • Simplex Trading first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 14 quarters.
  • Simplex Trading's Adamas Pharmaceuticals position peaked at $762K in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.